The press shrugs — how Biden made beating Covid look easy

New Post Public Reply Private Reply Replies (1) Message Board
Bhawks Goodspeed65 #63969
287
The press shrugs — how Biden made beating Covid look easy

No media victory laps

Eric Boehlert

https://pressrun.media/p/the-press-shrugs-bid...0pxG3iW_II

The welcome announcement from New Jersey this week that fully vaccinated people there will no longer have to wear masks inside stores and that indoor sporting events can soon return to 100 percent capacity, in a state that was hit especially hard by the Covid-19 virus, was just the latest, sweeping example of America emerging from the pandemic. With 130 million Americans fully vaccinated, and millions of children soon to join the ranks, the country is putting the pandemic in the rearview mirror.

It’s been a miraculous worst-to-first turnaround under President Joe Biden, who inherited a Covid crisis at its zenith, with nearly 3,000 American deaths each day. It was a virus calamity that had been mismanaged nearly every day of 2020 by Trump and his virus-denying advisors.

Trashing science and urging people to inject bleach into their bodies, Trump oversaw the worst government response to a public health crisis in U.S. history — 400,000 Americans likely died because of Trump’s incompetence.

He spread more deliberate lies about Covid to a larger audience than anyone else on the planet, according to a study from Cornell University. "When it gets a little warmer, it miraculously goes away," he once predicted.

Under Biden, that nightmare has been turned into an American success story, as the vaccination rollout continues to be a model for the world.

That victory was note pre-ordained. Back in January, the Christian Science Monitor noted, “He faces steep obstacles, with the virus actively spreading in most states, slow progress on the vaccine rollout, and political uncertainty over whether congressional Republicans will help him pass a $1.9 trillion economic relief and COVID-19 response package.”

But Biden pulled it off, far exceeding expectations. So how come he never got a victory lap in the press? Why has the media decided to instantly move on from one of the biggest news stories of the last century — how Covid-19 crippled America and killed more than 600,000 people here.

Has the Beltway press in the Biden era simply adopted the mantra that only bad news is real news? Politico actually posted this April headline: "How Good News Could Complicate the Biden Agenda." Note that just 25 percent of Biden’s early news coverage was positive, according to a study from Pew.

The migrant surge at the border? That’s considered big news by the media, and Biden was personally responsible for it. The cyber-attack on the Colonial Pipeline, fighting in the Middle East, a disappointing April jobs report. All of those stories received excited coverage in recent weeks, while Biden’s stunning vaccination success receives mostly shrugs.

There’s clearly a partisan angle to this, because by turning away from Biden’s Covid victory, the press is following the GOP’s lead. Republicans have no interest in dwelling on America’s stunning vaccination turn-around, and apparently neither does the press. During Biden’s inaugural press conference, he wasn’t asked a single question about Covid, which had dominated American life for 15 months.

That, despite the fact that the press conference featured Biden announcing that the new goal was to have 200 million Americans receive a shot within the first 100 days of his presidency — an unthinkable benchmark compared to the national embarrassment the vaccine rollout had been under Trump.

Today, rather than acknowledging Biden’s stunning Covid accomplishment, the press is racing ahead to flag all the looming problems the White House supposedly faces, while often completely ignoring the startling pandemic win. “Biden Battles New Crises as Honeymoon Fades,” NBC’s “Meet the Press” recently announced.

The Washington Post this week warned that Biden’s “big agenda is imperiled as his priorities stall in Congress,” without mentioning that the number one priority on Biden’s agenda — safely reopening the country — has already been achieved with miraculous speed.

CNN posted a nearly simultaneous dispatch, about the slow-motion state of Biden’s legislative agenda, claiming it was causing distress among progressive Democrats. ( CNN politely glossed over the fact that radical GOP obstruction is what has slowed the agenda.) Nowhere in the 1,400-word piece was there mention of Biden’s Covid accomplishments.

Incredibly, when the White House’s pandemic win is referenced, it’s sometimes framed as bad news for Biden, as this recent Politico headline demonstrates: “Vaccines' Success Could Undercut Biden's Multibillion-Dollar School Testing Plans.” And from the Post: “Biden’s Vaccination Success Story is About To Run Into a World of Pressure.”

The New York Times this week stressed that the post-Covid economic recovery is so strong that it’s creating problems for the White House: “State Revenues Pour In, Raising Pressure on Biden to Divert Federal Aid.”

The vaccination rollout has been too successful, basically. For Biden, it’s more heads you lose, tails you lose coverage.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

UAE Ties Diplomacy, Media and AI Into a Shared Signal

Updated Category News Views 128

Influence is getting harder to measure, and easier to squander, which is why the message from Ajman deserves more than a polite nod. At the 2026 Ajman Media Forum, THE SIGNAL, Foreign Affairs Undersecretary Omar Obaid Alhesan Alshamsi made the UAE’s position plain: diplomacy and media are no longer separate lanes. Both operate on words, context, trust and the difficult...

Continue Reading
UAE Trust Model Faces Its Hardest Test During Crisis

Updated Category News Views 394

A country’s reputation is usually invisible right up until the machinery rattles. Then people, investors, trading partners and residents stop listening to polished slogans and start watching whether airports function, services hold up, information arrives, and business can keep moving. That was the useful core of Saeed Al Eter’s remarks at Ajman Media Forum 2026: soft...

Continue Reading
DKSH's Vietnam Oncology Pact Carries Real Promise, Risk

Updated Category News Views 58

A cancer-market announcement ought to make investors pause before they reach for a spreadsheet. Specialised Therapeutics and DKSH have signed an exclusive partnership to bring oncology therapies into Vietnam, and the human case is painfully clear: the country recorded an estimated 180,000 new cancer cases and more than 120,000 deaths annually in the 2022 GLOBOCAN data....

Continue Reading
NatGasHub’s 391% Growth Signals a Real Pipeline Shift

Updated Category News Views 459

Three hundred-plus pipelines is a lot of messy plumbing to tame, and NatGasHub has apparently found a lucrative way to do it. The Houston software company landed at No. 182 on Deloitte’s 2026 Technology Fast 500 after reporting 391% revenue growth from 2022 through 2025. That is a serious number, even in a ranking built to showcase companies sprinting uphill. More...

Continue Reading
AutoShop Answers Extends 2027 Training Into Fridays

Updated Category News Views 83

A repair bay can hum all day while the back office quietly bleeds profit. That unglamorous reality is why AutoShop Answers adding nine Friday specialty classes to its 2027 Key2Key Weekend calendar deserves a closer look. This is not a new tool chest or some vague motivational roadshow; it is an attempt to give independent shop owners an extra day to work on the pieces...

Continue Reading
CARsgen's CT1182 Data Opens a Careful New CAR-T Test

Updated Category News Views 140

Six very sick lymphoma patients are not a victory lap, but they can still make the whole cell-therapy field sit up straighter. CARsgen has disclosed first clinical results for CT1182, an in vivo CAR-T candidate built on its CARvivo platform, and the early package is plainly more interesting than the usual preclinical chest-thumping. The company reported three complete...

Continue Reading
Mission Inn’s Lights Enter a Tender New Ownership Era

Updated Category News Views 661

A holiday spectacle can outlive the hands that hung its first bulb. Riverside is about to test that truth in public, under millions of tiny lights and the very large shadow of a family departure. The Mission Inn Festival of Lights returns in 2026 without Kelly and Duane Roberts as hotel owners for the first time in more than three decades. Duane Roberts died in 2025, the...

Continue Reading
PHONO's 150 MW RE+ Win Tests Its U.S. Solar Staying Power

Updated Category News Views 570

A trade-show order book is not cash in the bank, but 150 MW is still a number worth circling in red. PHONO used RE+ 2026 in Las Vegas, held November 17 through 19, to celebrate 20 years in business, parade its solar and storage lineup, and announce new U.S. orders. In a solar market that has become touchier about provenance, compliance and delivered economics, the company...

Continue Reading
Ajman Memory Gives Heritage a Durable Digital Backbone

Updated Category News Views 318

Archives usually get applause only after somebody realizes a piece of history has vanished. Ajman is trying to skip that miserable part. During the Ajman Media Forum 2026, held November 18 and 19 at the Emirates Hospitality Centre, the emirate launched Ajman Memory, a project built to collect, document and preserve photographs, papers and video recording its development....

Continue Reading
Luca's Campo Morado Denial Makes Guerrero Risk Clear

Updated Category News Views 19

A Dangerous Headline Needs More Than a Quick Rebuttal One ugly allegation can do more damage to a junior miner than a lousy quarter, especially when it involves a mine in Guerrero State and alleged criminal control. Luca Mining has flatly rejected Mexican media reports claiming that its Campo Morado Mine is controlled by a criminal organization. The company says the...

Continue Reading

Top 5 Most Recently Viewed Articles

Leidos' Autonomous Vessels Chart Bold Naval Waters

Updated Category News Views 49

Leidos' Autonomous Leap with the U.S. Navy Well, today it's all about Leidos, an outfit that's been showing its grit in the world of maritime autonomy. Their systems aren't just tinkering around anymore—they're slicing through the waves at RIMPAC, the Rim of the Pacific, and running alongside the USS Theodore Roosevelt Carrier Strike Group. That's big news in anyone's...

Continue Reading
89bio to Showcase Pegozafermin Trial Insights at Major Conference

Updated Category News Views 67

89bio Presents Key Findings from ENLIVEN Phase 2b Trial 89bio, Inc. (NASDAQ: ETNB), a biopharmaceutical company committed to developing innovative treatments for liver and cardiometabolic diseases, has exciting news. The company will present new analyses from its Phase 2b ENLIVEN trial, which assesses the efficacy of pegozafermin in patients suffering from metabolic...

Continue Reading
New Insights on Penetrium's Role in Combating TNBC Growth

Updated Category News Views 487

Hyundai ADM Bio Unveils Promising Results for Penetrium – Groundbreaking treatment strategy targets both primary and metastatic tumors. Hyundai ADM Bio has announced significant findings related to its pioneering agent, Penetrium, which exhibited impressive anti-metastatic properties in recent preclinical studies involving triple-negative breast cancer (TNBC). This...

Continue Reading
Designer Brands Inc. Reveals Upcoming Earnings Call for Q1 2025

Updated Category News Views 178

Upcoming Earnings Release for Designer Brands Inc. Designer Brands Inc. (NYSE: DBI), a leading force in footwear and accessories, has announced an important date for shareholders and interested parties alike. The company is set to release its earnings for the first quarter of 2025 on June 10, 2025. This marks a significant event, as it gives insights into the company's...

Continue Reading
Harvard Bioscience, Inc. Reports Q1 2025 Financial Performance

Updated Category News Views 374

Strong Financial Insights from Harvard Bioscience Harvard Bioscience, Inc. (NASDAQ: HBIO) recently shared its financial results for the first quarter, showcasing a mixed performance influenced by various market factors. The company expressed confidence in its revenue management and highlighted new product developments that are energizing its business strategies. Revenue...

Continue Reading